Curing Duchenne Muscular Dystrophy with a New Version of CRISPRTechnology NetworksThe UT Southwestern group had previously used CRISPR-Cas9, the original gene-editing system, to correct the Duchenne defect in a mouse model of the disease and in human c… Continue reading
Imperial College LondonImperial branches out to develop synthetic biology in East AfricaImperial College LondonSynthetic biology experts from Imperial College London headed to East Africa to help identify where the field could have a life-changing impa… Continue reading
Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough …PR Newswire (press release)EAST HANOVER, N.J., April 18, 2017 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has granted Breakthrough …and m… Continue reading
Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough Therapy designation for treatment of adult patients …GlobeNewswire (press release)Basel, April 18, 2017 – Novartis announced today that the US Food and Drug Administration (FDA) has granted… Continue reading
Fred Hutch News ServiceNanoparticles reprogram immune cells to fight cancerFred Hutch News ServiceAs reported in the new study, Stephan and his team developed biodegradable nanoparticles that turned T cells into CAR T cells, a particular type of cellul… Continue reading
Clinical Oncology News |
CAR Therapy Research Heats Up
Clinical Oncology News Boston—While checkpoint inhibitors may be stealing the cancer news spotlight these days, advances in chimeric antigen receptor–modified T–cell therapy (CAR therapy) also have immuno-oncology investigators excited. “Hopefully, we will see approvals for … Nanoparticles reprogram immune cells to fight cancerFred Hutch News Service Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatmentGeekWire Nanoparticles To Fight Cancer? Immune System Can Be Reprogrammed With Them, Researchers SayInternational Business Times |
Clinical Oncology News |
CAR Therapy Research Heats Up
Clinical Oncology News Boston—While checkpoint inhibitors may be stealing the cancer news spotlight these days, advances in chimeric antigen receptor–modified T–cell therapy (CAR therapy) also have immuno-oncology investigators excited. “Hopefully, we will see approvals for … Nanoparticles reprogram immune cells to fight cancerFred Hutch News Service Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatmentGeekWire Nanoparticles To Fight Cancer? Immune System Can Be Reprogrammed With Them, Researchers SayInternational Business Times |